School of Medicine
Showing 101-200 of 761 Results
-
Philip C. Hanawalt
Dr. Morris Herzstein Professor in Biology, Emeritus
Current Research and Scholarly InterestsMy current interest includes two principal areas:
1. The molecular basis for diseases in which the pathway of transcription-coupled DNA repair is defective, including Cockyne syndrome (CS) and UV-sensitive syndrome (UVSS). Patients are severely sensitive to sunlight but get no cancers. See Hanawalt & Spivak, 2008, for review.
2. Transcription arrest by guanine-rich DNA sequences and non-canonical secondary structures. Transcription collisions with replication forks. -
Steven Hancock, MD
Professor of Radiation Oncology (Radiation Therapy), Emeritus
Current Research and Scholarly InterestsOutcomes of radiation treatment for prostate cancer. Clinical research interests in the late effects of radiation on normal tissues and chemical modification of radiation injury. Hodgkins's disease and late effects of radiation and combined modality therapy. Radiation sensitizers. Hypoxic cell cytotoxins. Esophageal cancers.
General adult and pediatric radiation therapy. -
Frank Hanley
Lawrence Crowley, M.D., Endowed Professor of Child Health
Current Research and Scholarly InterestsHis research and clinical work focuses on the development of interventional techniques for fetal and neonatal treatment of congenital heart disease, pulmonary, vascular physiology, and the neurologic impact of open-heart surgery. He developed and pioneered the unifocalization procedure, in which a single procedure is used to repair a complex and life-threatening congenital heart defect rather than several staged open-heart surgeries as performed by other surgeons.
-
Maha Hanna
Clinical Assistant Professor, Pediatrics
Current Research and Scholarly InterestsA bad latch means maternal excruciating pain, ineffective milk transfer with subsequent weight loss, hypoglycemia, higher risk of hyperbilirubinemia and dehydration fever.All of the above led to early cessation of breastfeeding; 46% of mothers who initiate exclusive breastfeeding stop within the first 12 weeks because of difficult latch. I developed a latch tutorial focusing on step-by step-in striations for achieving an effective, non-painful latch.
-
Josef Hannah
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Hannah graduated from Kansas City University of Medicine & Biosciences. He then completed a residency in Internal Medicine at the University of Kansas and a fellowship in Hospice & Palliative Medicine at Stanford University before joining as faculty at Stanford. His clinical practice includes both inpatient palliative care consultation as well as ambulatory care in palliative medicine. His research and educational interests include symptom management and utilizing media to grow palliative care services and education.
-
Mindy Hantke
Director of Communications, Psychiatry and Behavioral Sciences
Current Role at StanfordWeb & Communications Administration
-
Dina Hany
Postdoctoral Scholar, Biomedical Data Sciences
BioI am currently a postdoctoral researcher in the laboratory of Prof. Sylvia Plevritis, Department of Biomedical Data Sciences. My current work involves establishing drug testing platforms to evaluate tumor drug responses with respect to the tumor microenvironment and the its spatial organization. I hold a Ph.D. in Life Sciences (Pharmaceutical Sciences) from the University of Geneva, Switzerland, where I conducted research in Prof. Didier Picard's laboratory from 2017 to 2022. Prior to that, I earned a Master’s degree in Pharmacology and Experimental Therapeutics from Alexandria University, Egypt, and a Bachelor’s degree in Pharmacy with honors from Pharos University. My professional experience includes postdoctoral research in molecular pharmacology at UNIGE and a lecturer position in Pharmacotherapeutics and Cancer Biology at Pharos University. I have extensive teaching experience, supervising undergraduate and postgraduate courses, and have successfully guided master's thesis projects. My research has focused on endocrine resistance in breast cancer, utilizing CRISPR/Cas9 screens and exploring drug combinations, resulting in several relevant publications. I have presented my work at numerous conferences and received several awards, including the Ernst et Lucie Schmidheiny Fondation grant and the Ph.D. Booster prize from the faculty of medicine, Geneva, Switzerland. I am an active member of the Life Sciences Switzerland (LS2) and the European Association of Cancer Research (EACR).
-
Chenzhou Hao
Basic Life Res Scientist, Department of Neurobiology
BioMy expertise encompasses drug design, screening, and optimization. Currently, I am collaborating with my team to discover next-generation antiviral drugs targeting potentially pandemic viruses through structure-based drug discovery approaches.
My research interests include scientific visualization and structural biology, and I am eager to contribute to human health as a drug hunter in the future. In addition to my passion for research, I enjoy music, history, and architecture.
https://orcid.org/0000-0001-6803-7270 -
Md Enamul Haque
Biostatistician, Ophthalmology Research/Clinical Trials
Current Role at StanfordSr. Research Scientist
-
Pehr Harbury
Associate Professor of Biochemistry
Current Research and Scholarly InterestsScientific breakthroughs often come on the heels of technological advances; advances that expose hidden truths of nature, and provide tools for engineering the world around us. Examples include the telescope (heliocentrism), the Michelson interferometer (relativity) and recombinant DNA (molecular evolution). Our lab explores innovative experimental approaches to problems in molecular biochemistry, focusing on technologies with the potential for broad impact.
-
Antonio Hardan, M.D.
Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe neurobiology of autism
Neuroimaging in individuals with autism
Psychopharmacological treatment of children and adults with autism and/or developmental disorders
The neurobiology and innovative interventions of several neurogenic disorders including DiGeorge Syndrome (Velocardiofacial syndrome; 22q11.2 mutations), PTEN mutations, and Phelan McDermid Syndrome (22q13 mutations). -
Josef Hardi
Software Dvlpr 3, Computational Medicine
BioI'm a software engineer with over 15 years of experience building reliable, scalable software systems. I’m especially passionate about software engineering, data modeling, and the emerging potential of agentic large language models (LLMs).
I work at the Stanford Center for Biomedical Informatics Research, where I help develop Protégé and WebProtégé, which are tools used worldwide for creating and managing ontologies. Recently, I contributed to the Human BioMolecular Atlas Program (HuBMAP) project, where I helped build the Human Reference Atlas (HRA) knowledge graph and designed metadata schemas to support a range of assay datasets produced by the consortium.
My core technical strengths are in Java, JavaScript, and Python. I enjoy working at the intersection of software engineering and data to build tools that empower researchers and improve data interoperability. -
Kate Hardy
Clinical Professor, Psychiatry and Behavioral Sciences
BioKate Hardy is a California Licensed Psychologist who has specialized in working with individuals with psychosis for over 20 years in both research and clinical settings. Dr. Hardy received her doctorate in clinical psychology from the University of Liverpool, United Kingdom. She has worked in specialist early psychosis services in both the UK and the US, including UCSF’s Prodrome Assessment Research and Treatment (PART) program, where she completed her post-doctoral fellowship, and as Clinical Director for the Prevention and Recovery from Early Psychosis (PREP) program. Dr. Hardy is the co-director for the INSPIRE clinic at the Department of Psychiatry and Behavioral Health, Stanford University and has significant experience in providing CBTp to individuals with early psychosis, and those at risk of developing psychosis, in both individual and group settings and integration of this clinical intervention to broader systems and staff teams. Dr. Hardy is also involved in the implementation of national strategies to increase dissemination of early psychosis models with the aim of bringing these cutting edge treatments to a broader population and is the co-editor of the book Intervening Early: A team approach.
Dr. Hardy is also the director of INSPIRE training and within this role has led multiple trainings and workshops in CBTp to a wide variety of audiences including community clinicians, psychiatrists, and families, and provides ongoing supervision and consultation in this approach. INSPIRE training offers training in evidence based interventions for psychosis to providers across diverse settings. In 2024 Dr. Hardy became president elect for IEPA: Intervening Early in Mental Health. -
Aubrey Hargrave
Basic Life Research Scientist, Ophthalmology Research/Clinical Trials
BioMy research interests are centered on ocular immunology and neuroinflammation. My long-standing interest in eye research stems from personal experience with eye disease, which has led me to explore vision research and underlies my passion for disease-centric research in order to improve quality of life for patients.
I am fascinated by the immune response and inflammation, in part because of its broad applicability to many human diseases. To this end, I am interested in developing an understanding of the interplay between the immune and nervous systems in the ocular microenvironment and my past research has allowed me to explore this interplay within diverse areas of the eye. As an undergraduate, I conducted research with Dr. Rima Mcleod to study patients with toxoplasmosis, a disease affecting both ocular and neural tissue. We created a patient database and investigated whether genotype influences the inflammatory response to the t.gondii parasite. As a predoctoral student with Dr. Alan Burns, my research focused on ocular inflammation in two cases; first, in acute inflammation following a corneal abrasion and second, in the context of systemic inflammation caused by early metabolic syndrome. I analyzed the immune response in both cases and developed methods to determine the effect on corneal nerves.
During my postdoctoral training with Dr. Alfredo Dubra, I am continuing to build on my previous training in vision science, inflammation, and neurodegeneration by using adaptive optics imaging, in conjunction with standard clinical measurements, to explore potential biomarkers in diseases such as multiple sclerosis, glaucoma, and retinal degeneration. With high-resolution in vivo adaptive optics imaging we are able to monitor changes in retinal tissues at the cellular level over time, as well as to observe minute changes in the retina with treatment during clinical trials. -
Brian A. Hargreaves
Professor of Radiology (Radiological Sciences Laboratory) and, by courtesy, of Electrical Engineering and of Bioengineering
Current Research and Scholarly InterestsI am interested in magnetic resonance imaging (MRI) applications and augmented reality applications in medicine. These include abdominal, breast and musculoskeletal imaging, which require development of faster, quantitative, and more efficient MRI methods that provide improved diagnostic contrast compared with current methods. My work includes novel excitation schemes, efficient imaging methods and reconstruction tools and augmented reality in medicine.
-
Prashant Hariharan
Postdoctoral Scholar, Neurosurgery
BioPrashant Hariharan is a biomedical engineer specializing in the design of "fit-for-purpose" in vitro models to study neurological disorders. He earned his B.E. from the University of Mumbai, an M.S. from the University of Texas at Arlington, an M.Eng. from Cornell University and a PhD from Wayne State University. His doctoral work with Dr. Carolyn A. Harris focused on developing an "organ-chip" model of the choroid plexus to study how cerebrospinal fluid secretion is affected by hydrocephalus. As a postdoctoral scholar in the Fame lab, Prashant is adding new layers of physiological complexity to his previous model to investigate how the body’s circadian clock regulates choroid plexus-driven cerebrospinal fluid production and composition. This work aspires to deliver model-driven insights that can be translated into CSF-centric therapies and ultimately advance the pursuit of precision medicine for brain health.
-
Stephanie Harman
Clinical Professor, Medicine - Primary Care and Population Health
BioDr. Stephanie Harman is a palliative care physician and Clinical Professor of Medicine. She graduated from Case Western Reserve University School of Medicine and went on to complete a residency in Internal Medicine at Stanford and a Palliative Care fellowship at the Palo Alto VA/Stanford program. She then joined the faculty at Stanford. She co-founded the Palliative Care Program at Stanford Health Care in 2007 and served as Clinical Chief of the Section of Palliative Care in the Division of Primary Care and Population Health from 2016 - 2022. She was the inaugural Associate Chair for Women in Medicine for the Department of Medicine and is now the Associate Chair for Faculty Engagement and Leadership Development. She is Director of the Stanford Leadership Development Program, a joint program between Stanford Health Care and the School of Medicine for emerging leaders. A 2017 Cambia Health Foundation Sojourns Scholar Leader Awardee, she has a passion for leadership development and faculty engagement; she has built multiple programs to support the careers of women leaders in academic medicine, both locally and nationally. Her other professional interests include clinical ethics and serious illness communication.
-
Keren Haroush
Assistant Professor of Neurobiology
Current Research and Scholarly InterestsOur laboratory studies the mechanisms by which highly complex behaviors are mediated at the neuronal level, mainly focusing on the example of dynamic social interactions and the neural circuits that drive them. From dyadic interactions to group dynamics and collective decision making, the lab seeks a mechanistic understanding for the fundamental building blocks of societies, such as cooperation, empathy, fairness and reciprocity.
-
George Harpur
Graduate, Medicine, Radiology
BioGeorge Harpur is a Ph.D. student, joining Prof Daniel Ennis’ lab as a visiting graduate researcher in July 2026. His work focuses on developing methods for measuring cardiac strains from advanced magnetic resonance imaging (MRI), namely DENSE, and assessing their use in the diagnosis and prognosis of subclinical heart disease. This involves incorporating finite element and machine learning/deep learning methods, increasing the potential of advanced MRI techniques in clinical protocols.
George Harpur is a member of the Heart Mechanics Research Group at the Auckland Bioengineering Institute, University of Auckland, New Zealand. -
Ciara Harraher, MD
Clinical Professor, Neurosurgery
Current Research and Scholarly InterestsI am interested in medical education and I am an Associate in the Practice of Medicine and doctoring with CARE ( E4C) Program. I am also interested in surgical outcomes research and I am involved in clinical trials studying brain tumors and stroke. I have also presented internationally on issues related to improving diversity in Neurosurgery.
-
Anthony Harris
Postdoctoral Scholar, Genetics
BioAnthony Harris is a postdoctoral fellow in the Department of Genetics at Stanford School of Medicine, where he investigates the organization and function of the genome during cellular development. His research focuses on uncovering fundamental principles of chromosome structure, cellular differentiation, and genome stability. By combining experimental molecular biology, computational modeling, and third generation sequencing technologies, Dr. Harris aims to elucidate the mechanisms that shape chromatin architecture and direct genome maintenance. His interdisciplinary approach integrates cutting-edge quantitative analysis with traditional molecular techniques to advance understanding of the relationship between cellular organization and disease.
Dr. Harris has developed computational tools for genomic data analysis and applies data-driven strategies to study chromatin structure and gene regulation. His work has been published in leading journals, including EMBO Journal, Genetics, and Developmental Cell, with projects spanning meiosis regulation, transcriptional control, and genome integrity. These experiences reflect his commitment to understanding how chromatin organization and gene expression guide cell fate and function.
Dr. Harris earned his Bachelor of Science in Biochemistry from the University of Minnesota and his Ph.D. in Molecular and Cellular Biology from the University of California, Berkeley. He brings expertise in data analysis, computational biology, scientific writing, and collaborative research. His broad training spans biochemistry, cell biology, microbiology, genetics, and computational genomics. -
E. John Harris Jr.
Professor of Surgery (Vascular), Emeritus
Current Research and Scholarly InterestsI am interested in thrombosis and the role of thrombin and its receptor in venous wall remodeling following venous thrombosis. I am also interested in vascular hemodynamics and the use of ultrasound, MRI and computational modeling in evaluating arterial flow in exercise conditions.
-
Odette Harris, MD, MPH
Paralyzed Veterans of America Professor of Spinal Cord Injury Medicine
Current Research and Scholarly InterestsTraumatic brain injury with a focus on epidemiology and outcomes.
-
Sean Edmund Harris, MB BCh BAO
Clinical Assistant Professor, Surgery - Vascular Surgery
BioDr. Sean Edmund Harris is a board-certified vascular surgeon with Stanford Health Care Vascular and Endovascular Care. He is also an assistant professor in the Department of Surgery, Division of Vascular Surgery at Stanford University School of Medicine.
Dr. Harris specializes in creating and maintaining dialysis access, working closely with nephrologists to provide complex kidney disease care. His other interests include venous disease management and endovascular management of aortic and peripheral vascular diseases. As a physician-researcher, Dr. Harris has traveled around the world and brings extensive and diverse vascular education back to his patients. He also understands the needs of the local community as a San Francisco Bay Area native.
Dr. Harris has published his findings in several peer-reviewed journals, including Annals of Vascular Surgery, the Journal of the American College of Surgeons, the Journal of Vascular Surgery, and the Journal of Thoracic and Cardiovascular Surgery. He has also shared his expertise globally, presenting leading-edge vascular surgery research at prominent conferences of the Society for Vascular Surgery (SVS), the European Society for Vascular Surgery, and the International Aortic Summit.
Dr. Harris is a member of the New England Society for Vascular Surgery and the SVS. -
Natasha Harrison
Biostatistician 2, Anesthesiology, Perioperative and Pain Medicine
BioBiostatistician at SOM.
-
T. Kyle Harrison, MD
Staff, Anesthesia - Adult Pain Medicine
Clinical Professor (Affiliated), Multispecialty AnesthesiologyBioDr. T. Kyle Harrison is a Clinical Professor (Affiliated- PAVA) of Anesthesiology, Perioperative and Pain Medicine at Stanford University and a staff physician at the VA Palo Alto. He is board certified in both Anesthesiology and Addiction Medicine. He earned his MD and did his residency training in anesthesiology at Stanford University. He completed a medical education and simulation fellowship at Stanford and then obtained additional training in addiction medicine at both Stanford and the VA Palo Alto. He is interested in the intersection of pain and addiction. He co directs the Transitional Pain Clinic at the VA Palo Alto. He attends on both the acute pain service as well as the addiction medicine clinic at the VA Palo Alto. His academic interest include addiction, pain, peri operative management of buprenorphine, transitional pain, conversion of acute to chronic pain, and medical simulation. His email is kyle.harrison@stanford.edu and his twitter handle is @KyleHarrisonMD.
-
Geoffrey Hart-Cooper
Clinical Associate Professor, Pediatrics - General Pediatrics
Current Research and Scholarly InterestsDr. Hart-Cooper's research focuses on youth provider barriers and education surrounding pre-exposure prophylaxis for HIV (PrEP). He founded the Virtual PrEP Program for Adolescents and Young Adults at Stanford to improve access to PrEP care for youth within California. In his current role, he advises health departments and health systems in creating youth-focused telehealth tools to improve youth access to PrEP.
-
Phillip M. Harter, M.D.
Associate Professor (Teaching) of Emergency Medicine, Emeritus
Current Research and Scholarly InterestsMedical Education, particularly the role of simulation (part-task trainers, human patient simulators and virtual reality) in the education of medical students and residents. Also, the use of the internet for distance learning in health care professions.
-
Christy Hartman
Adm Svcs Admstr 1, School of Medicine - Biomedical Ethics
Current Role at StanfordProgram Manager, Medical Humanities and the Arts Program
-
Gary E Hartman, MD, MBA
Clinical Professor Emeritus, Surgery - Pediatric Surgery
Current Research and Scholarly InterestsMinimal Access and Robotic Surgery
Neonatal Surgery
Childhood Oncology -
Alica Hartmann
Affiliate, Pediatrics - Neonatology
BioAlica Hartmann is a postdoctoral researcher at the University Medical Center Mainz, Germany, with a background in public health, ophthalmology, and population-based epidemiology. Her work focuses on early-life risk factors and their long-term health consequences, with a particular interest in preterm birth, fetal growth restriction, and sex-specific differences in health outcomes. During her visiting research stay at Stanford, she will join the Department of Pediatrics to further develop her work in perinatal epidemiology.
-
Mary Elizabeth Hartnett, MD
Michael F. Marmor, M.D. Professor of Retinal Science and Disease and Professor of Ophthalmology
BioMary Elizabeth Hartnett, MD, is the Michael F. Marmor, M.D. Professor in Retinal Science and Diseases and is a Professor of Ophthalmology at Stanford University. Dr. Hartnett is the director of Pediatric Retina at Stanford University and principal investigator of a retinal angiogenesis laboratory, in which she studies causes and treatments for diseases including retinopathy of prematurity and age-related macular degeneration. She created the first-ever academic textbook on the subject, Pediatric Retina, in its third edition, which has proven to be an invaluable resource for residents and ophthalmologists internationally.
Dr. Hartnett’s NIH-funded laboratory of vascular biology and angiogenesis has studied mechanisms causing pathology in age-related macular degeneration (AMD) and retinopathy of prematurity (ROP). Her work in AMD has been to understand the mechanisms involved in activation and invasion of choroidal endothelial cells anterior to the RPE in order to maintain vasculature that is physiologic and not damaging beneath the RPE. Her lab has elucidated environmental stressors that lead to scarring in the macula for which no vision improvement is currently possible. The goal is to find methods to prevent the scarring.
Her lab’s work in ROP provided the proof of concept to regulate an angiogenic signaling pathway by inhibiting VEGF to facilitate intraretinal neovascularization as well as to inhibit abnormal extraretinal neovascularization and reduce retinal destruction used in previous treatments. Her work has been translated through clinical trials to lead to new treatments for severe ROP and has represented a paradigm shift in the understanding and treatment of severe ROP.
Dr. Hartnett has received numerous awards, including the Weisenfeld Award, the highest award for clinician-scientists given by the Association for Research in Vision and Ophthalmology (ARVO), in 2018, and is an ARVO Gold Fellow. She received the 2019 Paul Kayser/Retina Research Foundation Global Award, the Macula Society’s 2016 Paul Henkind Award and its 2019 Arnall Patz Medal, the Paul Kayser/RRF Global Award from the PanAmerica Society, and the 2021 Suzanne Veronneau-Troutman Award, the most prestigious award from Women in Ophthalmology. In 2022, she was one of six at the University of Utah to receive a distinguished research award, for Pediatrics and Ophthalmology. In recognition of her lifetime contributions, she was inducted into the Retina Hall of Fame and was elected to the Association of American Physicians in 2025.
Dr. Hartnett's prolific publication record includes 295 articles in peer-reviewed journals and over 40 book chapters. She has delivered numerous national and international invited lectures. Her long list of professional committee work includes serving as chair of the Publications Committee of ARVO, as a mentor for the ARVO Leadership Development Program, and in leadership positions internationally as the Treasurer for The Macula Society and the Chair of the Jack McGovern Coats Disease Foundation as well as the Credentialing Committee for The Retina Society. She reviews manuscripts for more than 20 eye and science journals and serves on the editorial boards of PlosOne, Molecular Vision, and the American Journal of Ophthalmology. Dr. Hartnett is a Fellow of the American College of Surgeons (FACS) and a Silver and Gold Fellow of the Association for Research in Vision and Ophthalmology (FARVO). -
Stella Hartono
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioStella Hartono, MD PhD is a board-certified allergy/immunology physician and clinical researcher. She specializes in diagnosing and treating immunology and allergic conditions, with a focus on immunodeficiency, immune dysregulation, hyper eosinophilia, and pet allergies.
Dr. Hartono’s clinical research focuses on the role of age-associated B cells in vaccine response and the aging immune system. She is also interested in improving diagnosis and treatment options for patients with CVID (common variable immunodeficiency) and SAD (specific antibody deficiency). She has published her original research in peer-reviewed scientific journals and presented at national conferences, including annual meetings for the Clinical Immunology Society and the American Academy of Asthma, Allergy, and Immunology, as well as international conferences, including annual meeting for the European Academy of Allergy and Clinical Immunology. Dr. Hartono is a member of the American Academy of Asthma, Allergy, and Immunology, the Clinical Immunology Society, and the American College of Allergy, Asthma, and Immunology. -
Grant Hartung
Affiliate, Rad/Radiological Sciences Laboratory
BioMy research includes developing custom mathematical models and algorithms to comprehensively simulate the biophysics underlying brain dynamics. These models are then used to simulate the detailed blood flow, volume, and oxygenation changes that accompany neural activity with a focus on detailed, realistic microvascular geometry to predict the impact of hemodynamic states and vascular structure on fMRI signals (for BOLD and non-BOLD sequences). This interdisciplinary work includes advances in mathematics, biophysics, neuroscience, and computer science to enable simulations of vascular structures orders of magnitude larger than previously possible in only a few hours.
These advancements have led to the quantification of many fMRI biases previously overlooked or undervalued. This includes the geometric blurring by the capillary bed between the site of neurovascular coupling and the venous response, ultimately measured by BOLD. Moreover, the microvascular blood volume at resting-state gave a non-neuronal explanation for the mid-cortex “bump” observed in layer-fMRI BOLD signals. This tool also proposed mechanistic explanations underlying the BOLD frequency nonlinearity observed during oscillatory stimulus. In non-BOLD acquisitions, these tools discovered artifacts in IntraVoxel Incoherent Motion (IVIM) and VAscular Space Occupancy (VASO) signals caused by vascular structural and flow asymmetries and velocity heterogeneity which help explain discrepancies in experimental findings with these methods.
Google Scholar: https://scholar.google.com/citations?user=ihwU5t8AAAAJ&hl=en
Email: grant.hartung@tu-darmstadt.de -
Earth Hasassri, MD
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Earth Hasassri is an Adjunct Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry and Child Development at Stanford University School of Medicine. He has a private practice in Menlo Park and teaches medical students, residents, and fellows at Stanford University School of Medicine. In his private practice, he specializes in seeing children and adults with complex psychiatric conditions such as ADHD, autism spectrum disorders, functional neurological disorders, those with epilepsy, and other neuropsychiatric conditions. His interests are caring for individuals who suffer from medical conditions at the interface of medicine and psychiatry.
Prior to medical school, Dr. Hasassri graduated with dual bachelor's degrees in neurophysiology and psychology at the University of California San Diego, where he performed research on sleep medicine. He earned his medical degree from the Mayo Clinic Alix School of Medicine where he did research in clinical epidemiology. Dr. Hasassri completed his residency in general psychiatry at the University of California San Francisco Langley Porter Psychiatric Hospitals & Clinics, during which he was awarded an Area of Distinction in Clinical Neuroscience for his work in applying neuroscientific principles in his clinical work in those with brain cancer, dementia, neurodevelopmental disorders, and other neuropsychiatric conditions. Dr. Hasassri is dual board certified in adult psychiatry and in child and adolescent psychiatry through the American Board of Psychiatry and Neurology, a member Board of the American Board of Medical Specialties. -
Elaheh Hashemi
Postdoctoral Scholar, Pathology
BioI am a postdoctoral researcher specializing in computational biology, bioinformatics, and multi-omics data analysis. My research focuses on integrating single-cell, spatial transcriptomic, and clinical datasets to better understand cellular heterogeneity and disease biology. I am passionate about using computational approaches to uncover biological mechanisms and translate complex datasets into insights that can ultimately improve human health. Outside of research, I enjoy hiking, mountaineering, camping, and playing the piano.
